EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 2,906 units of Bio-Rad A Common Stock and covered exercise/tax liability with 1,341 units of Bio-Rad A Common Stock, increasing direct ownership by 61% to 4,151 units (SEC Form 4)